Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
China flag China · Delayed Price · Currency is CNY
5.14
+0.01 (0.19%)
Feb 24, 2026, 3:04 PM CST

SHE:000597 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
7,3357,5317,6469,0518,3846,848
Market Cap Growth
1.44%-1.49%-15.52%7.95%22.43%1.46%
Enterprise Value
5,3314,7785,6677,4848,8158,080
Last Close Price
5.145.175.135.955.854.76
PE Ratio
19.3818.3821.3325.8484.66558.71
Forward PE
-24.8624.8624.8624.8624.86
PS Ratio
1.071.000.931.031.030.93
PB Ratio
1.311.351.481.921.951.66
P/TBV Ratio
1.611.681.792.372.422.09
P/FCF Ratio
11.7512.5721.7610.4713.3840.16
P/OCF Ratio
10.349.9313.038.1611.2312.00
EV/Sales Ratio
0.780.640.690.851.081.09
EV/EBITDA Ratio
5.374.696.229.9212.2011.64
EV/EBIT Ratio
12.4010.0415.4834.0941.8537.84
EV/FCF Ratio
8.547.9716.138.6614.0747.38
Debt / Equity Ratio
0.330.290.420.470.580.63
Debt / EBITDA Ratio
1.871.532.322.813.273.74
Debt / FCF Ratio
2.982.666.212.543.9715.25
Net Debt / Equity Ratio
-0.40-0.52-0.67-0.35-0.010.27
Net Debt / EBITDA Ratio
-2.31-2.82-3.80-2.18-0.091.61
Net Debt / FCF Ratio
-3.58-4.80-9.87-1.91-0.106.56
Asset Turnover
0.490.510.570.650.640.60
Inventory Turnover
3.553.533.974.504.043.62
Quick Ratio
0.950.870.860.780.650.57
Current Ratio
1.121.051.020.940.830.76
Return on Equity (ROE)
6.65%7.89%7.62%7.93%2.27%0.27%
Return on Assets (ROA)
1.91%2.00%1.57%1.02%1.04%1.08%
Return on Invested Capital (ROIC)
9.26%15.47%11.86%4.09%3.53%0.47%
Return on Capital Employed (ROCE)
6.90%7.70%6.40%4.10%4.20%4.40%
Earnings Yield
5.11%5.44%4.69%3.87%1.18%0.18%
FCF Yield
8.51%7.96%4.59%9.55%7.47%2.49%
Dividend Yield
1.95%1.93%1.95%1.68%0.24%0.17%
Payout Ratio
58.19%50.30%61.31%31.25%167.14%1019.51%
Buyback Yield / Dilution
1.21%1.43%-2.34%0.97%-15.42%8.41%
Total Shareholder Return
3.16%3.37%-0.40%2.65%-15.18%8.58%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.